FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2204139904> ?p ?o ?g. }

• W2204139904 endingPage "7" @default.
• W2204139904 startingPage "10" @default.
• W2204139904 abstract "Hyperthermic intraperitoneal chemotherapy (HIPEC) is often used to treat gastrointestinal malignancies and is of interest in epithelial ovarian cancer (EOC) given the propensity for intraperitoneal spread. The role of HIPEC in the treatment of gynecologic malignancies is not well defined. We sought to describe clinical characteristics and outcomes of our patient population treated with HIPEC.IRB approval was obtained. Patients diagnosed with EOC and treated with HIPEC from January 2007 until December 2013 were identified using a prospectively maintained HIPEC database. Patient charts were abstracted to identify patient demographic information, treatment characteristics, and outcome data. Statistical analysis was descriptive.Thirty-four patients were identified. Mean age at diagnosis was 56.5 years. The majority of cases (28, 82%) were of serous histology. The indications for HIPEC administration were as follows: 9% primary treatment, 41% first recurrence, 26% second recurrence, and 24% consolidative therapy in the setting of primary or recurrent disease. The majority of patients (21, 62%) received mitomycin C. The other drugs administered include cisplatin (10, 29%), oxaliplatin (2, 6%), and carboplatin (1, 3%). Mean length of hospital stay was 9 days (range, 3-39 days). The rates of postoperative bacteremia and hematologic toxicity were 6% and 54%, respectively. Seven (21%) patients developed transient renal dysfunction, and this was seen almost exclusively in the patients who received cisplatin. One (3%) additional patient had renal dysfunction that persisted longer than 30 days post-operative but did not go on to require dialysis. There were no perioperative deaths in this cohort. Eleven (32%) patients received additional chemotherapy following HIPEC administration. At a median follow-up of 20 months (range, 3-87 months), eight patients are alive with disease, seven have no evidence of disease, 14 have died of their disease, and five patients have been lost to follow-up.This data supports a reasonable side effect profile of treatment of EOC with HIPEC. Prospective studies are needed to elucidate the optimal drug and patient population that would derive the most benefit from treatment with HIPEC." @default.
• W2204139904 created "2016-06-24" @default.
• W2204139904 creator A5008540676 @default.
• W2204139904 creator A5019299853 @default.
• W2204139904 creator A5022379846 @default.
• W2204139904 creator A5028695126 @default.
• W2204139904 creator A5040538629 @default.
• W2204139904 creator A5044474059 @default.
• W2204139904 creator A5051030840 @default.
• W2204139904 creator A5070555068 @default.
• W2204139904 date "2016-02-01" @default.
• W2204139904 modified "2023-09-23" @default.
• W2204139904 title "Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancers: is there a role?" @default.
• W2204139904 cites W1485595432 @default.
• W2204139904 cites W1922469696 @default.
• W2204139904 cites W1967300023 @default.
• W2204139904 cites W1971608129 @default.
• W2204139904 cites W1973886552 @default.
• W2204139904 cites W1987281830 @default.
• W2204139904 cites W1998258610 @default.
• W2204139904 cites W2003563462 @default.
• W2204139904 cites W2004554342 @default.
• W2204139904 cites W2041430550 @default.
• W2204139904 cites W2042210669 @default.
• W2204139904 cites W2058126897 @default.
• W2204139904 cites W2086300174 @default.
• W2204139904 cites W2089333180 @default.
• W2204139904 cites W2098317319 @default.
• W2204139904 cites W2099521317 @default.
• W2204139904 cites W2102691587 @default.
• W2204139904 cites W2106767659 @default.
• W2204139904 cites W2111437716 @default.
• W2204139904 cites W2117224380 @default.
• W2204139904 cites W2123807913 @default.
• W2204139904 cites W2126235955 @default.
• W2204139904 cites W2130806638 @default.
• W2204139904 cites W2130941707 @default.
• W2204139904 cites W2136197422 @default.
• W2204139904 cites W2150120491 @default.
• W2204139904 cites W2154175915 @default.
• W2204139904 cites W2170552969 @default.
• W2204139904 cites W2170928115 @default.
• W2204139904 cites W2316501478 @default.
• W2204139904 cites W2328421677 @default.
• W2204139904 cites W2394492459 @default.
• W2204139904 cites W2613483874 @default.
• W2204139904 cites W271429962 @default.
• W2204139904 doi "https://doi.org/10.3978/j.issn.2078-6891.2015.103" @default.
• W2204139904 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4754311" @default.
• W2204139904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26941980" @default.
• W2204139904 hasPublicationYear "2016" @default.
• W2204139904 type Work @default.
• W2204139904 sameAs 2204139904 @default.
• W2204139904 citedByCount "5" @default.
• W2204139904 countsByYear W22041399042017 @default.
• W2204139904 countsByYear W22041399042018 @default.
• W2204139904 crossrefType "journal-article" @default.
• W2204139904 hasAuthorship W2204139904A5008540676 @default.
• W2204139904 hasAuthorship W2204139904A5019299853 @default.
• W2204139904 hasAuthorship W2204139904A5022379846 @default.
• W2204139904 hasAuthorship W2204139904A5028695126 @default.
• W2204139904 hasAuthorship W2204139904A5040538629 @default.
• W2204139904 hasAuthorship W2204139904A5044474059 @default.
• W2204139904 hasAuthorship W2204139904A5051030840 @default.
• W2204139904 hasAuthorship W2204139904A5070555068 @default.
• W2204139904 hasConcept C121608353 @default.
• W2204139904 hasConcept C126322002 @default.
• W2204139904 hasConcept C141071460 @default.
• W2204139904 hasConcept C143998085 @default.
• W2204139904 hasConcept C2776694085 @default.
• W2204139904 hasConcept C2778239845 @default.
• W2204139904 hasConcept C2779458272 @default.
• W2204139904 hasConcept C2780427987 @default.
• W2204139904 hasConcept C2780962732 @default.
• W2204139904 hasConcept C2781451048 @default.
• W2204139904 hasConcept C2908647359 @default.
• W2204139904 hasConcept C2994223192 @default.
• W2204139904 hasConcept C526805850 @default.
• W2204139904 hasConcept C71924100 @default.
• W2204139904 hasConcept C99454951 @default.
• W2204139904 hasConceptScore W2204139904C121608353 @default.
• W2204139904 hasConceptScore W2204139904C126322002 @default.
• W2204139904 hasConceptScore W2204139904C141071460 @default.
• W2204139904 hasConceptScore W2204139904C143998085 @default.
• W2204139904 hasConceptScore W2204139904C2776694085 @default.
• W2204139904 hasConceptScore W2204139904C2778239845 @default.
• W2204139904 hasConceptScore W2204139904C2779458272 @default.
• W2204139904 hasConceptScore W2204139904C2780427987 @default.
• W2204139904 hasConceptScore W2204139904C2780962732 @default.
• W2204139904 hasConceptScore W2204139904C2781451048 @default.
• W2204139904 hasConceptScore W2204139904C2908647359 @default.
• W2204139904 hasConceptScore W2204139904C2994223192 @default.
• W2204139904 hasConceptScore W2204139904C526805850 @default.
• W2204139904 hasConceptScore W2204139904C71924100 @default.
• W2204139904 hasConceptScore W2204139904C99454951 @default.
• W2204139904 hasIssue "1" @default.
• W2204139904 hasLocation W22041399041 @default.
• W2204139904 hasOpenAccess W2204139904 @default.

• next